Browse drugs

…ship of baseline characteristics to response in those receiving ACZ. Results are displayed as odds ratio (95% confidence interval).…

…/TDF) were assessed by a multivariable logistic regression. For CAB-LA, injections were classified as on time (within ±7 days from the…

…t common limitation (110 trials, 55.3%). Compared with placebo, calcium channel blockers (mean difference (MD) −1.78 (95% CI −2.96 to −0.60), moderate c…

…ses decreased mortality and morbidity, but the effectiveness of mycophenolate immunosuppression treatment reduces ILD progression by 75.5%. T…

…to TAF, -1.8 (95%CI: -3.9–0.3) kg per year in those switched to TDF, and -1.0 (95%CI: -3.1–1.8) kg per year in those on other backb…

… observed, suggesting an immune-mediated antitumor mechanism of CJRB-101. A total of 42 patients were enrolled in the low-dose cohort (o…

…wed no significant differences between sacubitril/valsartan and dapagliflozin (win ratio, 1.15; 95% CI 0.71 to 1.88), or between torsemide an…

…n remission at 52 weeks compared with 11 out of 40 (28%) in the IVIg/placebo group, with a difference of 10% (95% CI −11 to 31; p=0.…

…the efficacy and safety of two cycles of induction therapy with bevacizumab and paclitaxel followed by atezolizumab and nab-paclitaxel comp…

…ufactured GLP-1RA products (active ingredients: liraglutide and semaglutide) in people with type 2 diabetes and/or overweight/obesity. Pote…

…tion was 87.3±106.1 µm with aflibercept and 113.1±136.7 µm with faricimab. Adjusted mean reductions were 95.4 µm and 99.8 µm, respectivel…

…ted their STI Treatment Guidelines to recommend multi-dose oral metronidazole (MTZ) for all T. vaginalis-infected women. Although multi-dose …